Arkolith/Insider Trading/ENSC/Form 4

Gower Bob G

DirectorEnsysce Biosciences, Inc. (ENSC) · full profile →Form 4 · filed Mar 2, 2023
Net Buying
Open-Market Buys
$183K
Open-Market Sells
$0
Net Open-Market Flow
$183K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 1, 2023Buy(P)270K$0.48$130K1.1M
Feb 28, 2023Buy(P)109K$0.49$54K862K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-006553) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML